𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PCN82 COST COMPARISON OF BEVACIZUMAB PLUS CISPLATIN AND GEMCITABINE VERSUS PEMETREXED AND CISPLATIN THERAPY IN PATIENTS WITH ADVANCED OR RECURRENT NON-SQUAMOUS NON-SMALL CELL CANCER IN GERMANY – AN UPDATED ANALYSIS

✍ Scribed by HG Bischoff; A Hermes; DF Heigener; S Cesaro-Tadic; S Walzer; M Nuijten


Book ID
118609856
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
70 KB
Volume
13
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES